Arcturus Therapeutics Holdings Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -1.5% | +10.9% | +0.6% | +0.3% | -10.2% | -2.2% | -2.7% | -2.1% | -10.6% | -3.5% | -2.3% | – | |
| – | -4.9% | +14.4% | -6.6% | +0.7% | -5.4% | -25.8% | -6.9% | -7.6% | +19.0% | -36.6% | -2.2% | – | |
| – | – | +605.5% | -331.5% | – | – | -242.1% | – | – | – | -13.1% | -141.2% | – | |
| – | -10.8% | -72.6% | +36.7% | -75.6% | -96.9% | +5,494.1% | -100.0% | – | -23.9% | -100.0% | – | – | |
| – | -10.8% | -72.6% | +36.7% | -75.6% | -96.9% | +5,498.7% | -99.5% | +27,324.2% | – | -61.1% | -47.1% | – | |
| – | – | – | – | – | – | – | -200.0% | -100.0% | – | – | – | – | |
| – | -185.4% | – | +9.8% | -71.2% | -80.7% | +11,239.6% | -196.9% | – | +854.1% | -99.9% | +0.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.